HeartSciences Inc. Files Additional Definitive Proxy Soliciting Materials
HeartSciences Inc. submitted a Form DEFA14A filing with the SEC on November 4, 2026.
Stocks · News reference
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session. The company's market cap stands at $6.2 million. As per the news, the Q2 earnings report came out 2 days ago.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
HeartSciences Inc. submitted a Form DEFA14A filing with the SEC on November 4, 2026.
Premier Miton Group plc has disclosed a reduction in its shareholding in Ironveld PLC, falling from 7.878659% to 4.252749%.
Pasithea Therapeutics has received FDA clearance for its Investigational New Drug (IND) application to begin clinical development of PAS-004 for the treatment of NF1-associated cutaneous neurofibromas.
Picard Medical, Inc. has appointed Richard Fang, Ph.D., as its permanent, full-time Chief Executive Officer, effective October 28, 2026.
Filed: 2026-11-03 AccNo: 0001185185-26-005151 Size: 203 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Filed: 2026-11-03 AccNo: 0001437749-26-034708 Size: 164 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers